Rock Creek Pharmaceuticals Inc (RCPIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Sales | 46,109 | 37,199 | 1,595 | 36,270 | 57,478 |
| Cost of Goods | 37,738 | 30,314 | 169 | 31,166 | 47,976 |
| Gross Profit | 8,371 | 6,886 | 1,425 | 5,104 | 9,503 |
| Operating Expenses | 8,148 | 9,828 | 5,047 | 9,962 | 9,657 |
| Operating Income | 961 | -2,629 | -3,453 | -4,693 | 821 |
| Interest Expense | 305 | 217 | 179 | 543 | 0 |
| Other Income | 45 | 52 | 35 | 652 | 242 |
| Pre-tax Income | 701 | -2,793 | -3,596 | -4,585 | 1,063 |
| Income Tax | 319 | -1,156 | -1,099 | -1,981 | 552 |
| Net Income Continuous | 382 | -1,637 | -2,498 | -2,604 | 511 |
| Net Income Discontinuous | N/A | N/A | 3,076 | N/A | N/A |
| Net Income | $382 | $-1,637 | $578 | $-2,604 | $511 |
| EPS Basic Total Ops | 0.25 | -0.75 | 0.25 | -1.25 | 0.25 |
| EPS Basic Continuous Ops | 0.16 | -0.69 | -1.00 | -1.09 | 0.21 |
| EPS Basic Discontinuous Ops | N/A | N/A | 1.25 | N/A | N/A |
| EPS Diluted Total Ops | 0.25 | -0.75 | 0.25 | -1.25 | 0.25 |
| EPS Diluted Continuous Ops | 0.16 | -0.69 | -1.00 | -1.05 | 0.21 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 1.25 | N/A | N/A |
| EBITDA(a) | $1,670 | $-2,431 | $-3,259 | $-3,475 | $2,352 |